Center for Genomic Interpretation Launches ELEVATEGENETICS BRILLIANT Program™Innovative technical competency assessment is a game changer in evaluating the accuracy of genetic and genomic lab testing and results reporting Annapolis, MD / PRWeb / May 27, 2021 – The...
When a healthcare provider orders a genetic or genomic test for a patient, the patient's sample (blood, saliva, or tissue) is sent to a genetic testing laboratory, and then a report comes back indicating the presence or absence of genetic variants in the patient...
Over a Friday and Saturday in late April 2021, genetic counselors from every hospital genetics program across Utah volunteered their time to participate in a film shoot for clinician education videos that will be launched in late summer 2021 on the TestWisely.org...
CGI’s co-founder and CEO, Dr. Julie Eggington, was a winner of a 2019 Sego Award in Innovation in Technology as a leader in Utah’s business community, a unique accomplishment for the leader of a nonprofit organization. She was recently interviewed by Salt Lake City’s...
“Aligning Genetic and Genomic Test Reimbursement With Value of Tests” is an invited article just published in Clinical Laboratory News of the American Association for Clinical Chemistry, authored by CGI’s Drs. Eggington and Garlapow. They summarize issues with...
CGI’s co-founder, Dr. Julie Eggington, and CGI’s ELEVATEGENETICS Standards Committee member, Dr. John Pfeifer, were interviewed by the American Society of Hematology for their article “Demystifying DNA Variant Reporting”, published on December 1, 2020. Dr. Pfeifer...
CGI presented its work on how pathogenic variant classifications are not always well-supported by evidence. Working together with genetic counselors from Rocky Mountain Cancer Centers and Texas Oncology, CGI collected de-identified patient reports and examined the...
At the National Society of Genetic Counselors Annual Education Conference, CGI presented a poster on “Calculating and Communicating Error Estimates for Pathogenic Variant Classifications in Germline Sequence Tests.” The poster focused on CGI’s creation of a Positive...
Dr. Julie Eggington, Co-founder and CGI CEO, was asked by the press to comment on the outcomes of the Williams v Quest/Athena variant classification lawsuit: “Experts acknowledged...that variant classification remains a growing source of lab liability that the genetic...
CGI presented the poster “Calculating and Communicating Error Estimates for Pathogenic Variant Classifications in Germline Sequence Tests” at the Annual Meeting of the American Society of Human Genetics. The poster won the “Reviewer’s Choice Award”, meaning it was...